(Q40975482)

25 September 2017

1 reference

title

The outcomes movement and new measures of the severity of psoriasis (English)

1 reference

25 September 2017

Mckenna KE

1

1 reference

25 September 2017

Stern RS

series ordinal

2

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 March 1996

1 reference

Journal of the American Academy of Dermatology

25 September 2017

published in

1 reference

25 September 2017

volume

34

1 reference

25 September 2017

issue

3

1 reference

25 September 2017

page(s)

534-538

1 reference

Psoriasis -- a preliminary questionnaire study of sufferers' subjective experience.

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Skin disease and handicap: an analysis of the impact of skin conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

A survey of the social and psychological effects of psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Lepra, psora, psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Research needs in 11 major areas in dermatology. I. Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

1 reference

7 January 2021

The outcomes movement--will it get us where we want to go?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Shattuck lecture--outcomes management. A technology of patient experience

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Assessment and accountability: the third revolution in medical care

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

The concept of quality of life.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Measurement of health status in the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Measurement of functional capacity with visual analogue scales

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Measuring health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Measuring health status in arthritis. The arthritis impact measurement scales.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

The Sickness Impact Profile: Development and Final Revision of a Health Status Measure

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: a randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Measurement of involved surface area in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Severe Psoriasis – Oral Therapy with a New Retinoid

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

On the limitations of the psoriasis area and severity index (PASI)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

The size of lesions, or point counting as a step toward the solution of the PASI problem

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Site variation in anthralin inflammation on forearm skin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Measurement of cutaneous inflammatory reactions using a scanning laser-Doppler velocimeter

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Feelings of stigmatization in patients with psoriasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Psoriasis: an audit of patients' views on the disease and its treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Economic evaluation of new drug therapies in terms of improved life quality.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

The classification of psychiatric morbidity in attenders at a dermatology clinic.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

A psychocutaneous profile of psoriasis patients who are stress reactors. A study of 127 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Psoriasis-an index of disability

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Validation of Sickness Impact Profile and Psoriasis Disability Index in Psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

The relationship between disease severity, disability and psychological distress in patients undergoing PUVA treatment for psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

Prioritization of health services. The Oregon Basic Health Services Act and its implications for dermatologists and patients with dermatologic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

A critical appraisal of the quality of quality-of-life measurements

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990469-7

7 January 2021

10.1016/S0190-9622(96)90469-7

Identifiers

DOI

1 reference

25 September 2017

1 reference